Sulfafurazole
Sulfafurazole (INN, also known as sulfisoxazole) is a sulfonamide antibacterial with an dimethyl-isoxazole substituent. It possesses antibiotic activity against a wide range of Gram-negative and Gram-positive organisms. It is sometimes given in combination with erythromycin (see erythromycin/Sulfafurazole) or phenazopyridine. It is used locally in a 4% solution or ointment.
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a601049 |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Excretion | Excreted unchanged in urine |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.418 |
Chemical and physical data | |
Formula | C11H13N3O3S |
Molar mass | 267.30 g·mol−1 |
3D model (JSmol) | |
Melting point | 194 °C (381 °F) |
SMILES
| |
InChI
| |
(what is this?) (verify) |
See also
External links
- Sulfisoxazole at the US National Library of Medicine Medical Subject Headings (MeSH)
- MedlinePlus DrugInfo medmaster-a601049
- MedlinePlus DrugInfo medmaster-a601115
- Diseases Database (DDB): 30455
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.